Bank of America
AGIO icon

Bank of America’s Agios Pharmaceuticals AGIO Stock Holding History

Bank of America’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-30,000
Closed -$850K – 7756
2023
Q2 		$850K Buy
30,000
+300
+1% +$7.46K ﹤0.01% 4902
2023
Q1 		$682K Buy
+29,700
New +$789K ﹤0.01% 5161
2019
Q2 		– Sell
-126,700
Closed -$8.54M – 7150
2019
Q1 		$8.54M Buy
126,700
+86,400
+214% +$5.03M ﹤0.01% 2649
2018
Q4 		$1.86M Buy
+40,300
New +$2.49M ﹤0.01% 3909
2018
Q2 		– Sell
-35,200
Closed -$2.88M – 7058
2018
Q1 		$2.88M Buy
+35,200
New +$2.72M ﹤0.01% 3591

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $508M AUM 163.77% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Bank of America's AGIO Position: Q1 2026 in Review

Bank of America reduced its Agios Pharmaceuticals (AGIO) stake by 5.8% in Q1 2026, selling an estimated $891K and leaving 507,900 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2527.

Bank of America first reported a position in AGIO in Q4 2013 and has held it in 50 quarters since. The position peaked at $45.4M in Q3 2025. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Bank of America held 507,900 shares of Agios Pharmaceuticals worth $17.2M as of Q1 2026.
  • Bank of America sold 31,441 Agios Pharmaceuticals shares in Q1 2026, an estimated $891K.
  • Agios Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2527 holding.
  • Bank of America first reported a position in Agios Pharmaceuticals in Q4 2013 and has held it in 50 quarters since.
  • Bank of America's Agios Pharmaceuticals position peaked at $45.4M in Q3 2025.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.